Oak (oaklovesyou.com) is an online GLP-1 weight-loss clinic offering compounded semaglutide from $133/mo — the lowest standard monthly rate in our 13-clinic ranking — with an oral needle-free option, optional NAD+ and longevity add-ons, and no subscription lock-in. This Oak review scores it 7.7/10 on our independent five-criteria rubric: #4 overall, with an 8.0 for pricing, 7.5 for clinical oversight, 8.0 for treatment options, 8.0 for patient experience, and 7.0 for transparency. If you are comparing GLP-1 options and want to know whether Oak's unusually low entry price, needle-free oral route, and no-commitment structure make it the right program for you, this Oak review covers what $133/mo actually includes, what you give up versus higher-ranked peers, and when Oak is the clearest choice.
Independent review. We do not prescribe or sell medication. Prices sourced from oaklovesyou.com, June 2026. Updated July 2026.
Oak review: our verdict at a glance
Our Oak review evaluates the #4-ranked clinic in our independent GLP-1 provider ranking. Oak's competitive position is unusual: it starts cheaper than every other oral-and-injectable clinic we track ($133/mo vs $146/mo at Yucca Health, $147/mo at Wellorithm) yet delivers LegitScript certification, a needle-free oral route, optional NAD+/longevity add-ons, free shipping, and health coaching — all without requiring a multi-month subscription. That combination is rare at this price point.
Visit Oak → compounded semaglutide from $133/mo, $50 off first month
We may earn a commission at no cost to you if you start care through a link on this page. This Oak review was conducted independently of any affiliate arrangement; see affiliate disclosure.
Our full Oak review score:
| Criterion | Weight | Score |
|---|---|---|
| Pricing & value | 25% | 8.0/10 |
| Clinical oversight | 25% | 7.5/10 |
| Treatment options | 20% | 8.0/10 |
| Patient experience | 15% | 8.0/10 |
| Transparency & trust | 15% | 7.0/10 |
| Overall | 7.7/10 |
Verdict: Our Oak review finds a clinic that earns its #4 position through a tight combination — the lowest no-prepay monthly semaglutide rate we track, a needle-free oral route, NAD+ add-ons, and no subscription lock-in, all inside a LegitScript-certified program. The gap between #4 (Oak, 7.7) and #3 (Yucca Health, 7.8) is narrow: Oak scores 7.5 on clinical oversight vs Yucca's 8.0, reflecting a somewhat thinner independent patient-outcome track record. The main caveat this Oak review found is that Oak does not publish a state-by-state availability list, so patients must confirm eligibility at checkout. For patients who want the cheapest no-commitment entry into a licensed GLP-1 program with a needle-free option, Oak is one of the strongest structural fits in the ranking.
Is Oak legit?
Yes. This Oak review identified the following material trust signals:
- LegitScript-certified — the independent healthcare compliance standard used by Google, Visa, and major ad networks; the certification badge is verified in Oak's site footer
- Licensed U.S. provider review before prescription — Oak's intake is reviewed by a licensed provider before any treatment is authorized; no prescription is issued without clinician approval
- No subscription required — Oak explicitly markets a no-lock-in model: patients can stop after any monthly billing cycle without a penalty; a genuine structural differentiator in a field where 3- and 6-month bundles are the default
- Free shipping on all orders — temperature-controlled, tracked shipping included at the listed monthly price
Transparency caveat (score 7.0): This Oak review found two presentation gaps that hold the score below 8.0. First, Oak does not publish a state-served list on its pricing page; the FAQ implies state-by-state availability, but which states are covered is not listed before intake. Second, the first-month promo ($50 off) and the 3-month package deal are not maximally prominent in the pricing presentation. Neither is a red flag for legitimacy — both are presentation issues rather than conduct concerns.
Independent-review caveat: Oak's GLP-1 program is a newer addition to our ranking, and the independent patient-review corpus (Trustpilot, Reddit) is thinner than for peers with longer track records like Yucca Health (Trustpilot 4.6/5, 1,000+ reviews). Thinner track record does not mean Oak is problematic; it means independent outcome verification requires more deference to structural trust signals (LegitScript, licensed oversight) at this stage. This Oak review weights both accordingly.
The compounding caveat (required YMYL disclosure): Compounded semaglutide and tirzepatide are not FDA-approved drugs. They are prepared by licensed 503A compounding pharmacies under individual patient prescriptions — the legally compliant pathway under current FDA guidance. The active molecules belong to the same class as Wegovy and Ozempic, but purity, potency, and sterility have not been independently FDA-reviewed. We include this in every review on this site. For the full regulatory picture, see our compounded GLP-1 legal status guide and the FDA's compounding policy.
How much does Oak cost in 2026?
Pricing is the strongest differentiator our Oak review found: the $133/mo rate is a standard monthly price, not a 6-month prepay gate and not a teaser that resets higher at month 2.
Semaglutide: $133/mo — verified June 2026 directly from oaklovesyou.com. This is the ongoing monthly rate with no subscription required. Oak also offers a $50-off-first-month promo (effective ~$83 in month 1) and a $200-off-3-month-package deal for patients who prefer prepay. Either way, the $133/mo ongoing rate is not gated behind a commitment.
Tirzepatide: $199/mo — also from oaklovesyou.com, June 2026. Compounded tirzepatide (dual GLP-1/GIP, same class as Zepbound and Mounjaro) starts at $199/mo — the cheapest compounded tirzepatide entry in our ranking.
| Plan | Monthly Cost |
|---|---|
| Semaglutide (standard monthly) | $133/mo |
| Semaglutide (first month, promo) | ~$83/mo |
| Semaglutide (3-month package) | Lower effective rate |
| Tirzepatide (standard monthly) | $199/mo |
Prices from oaklovesyou.com, June 2026. Oak's site may block cloud verification agents — confirm current pricing directly before purchasing.
What is included: licensed provider consultation, prescription, free shipping with tracking, health coaching, all refills at the monthly rate. Optional NAD+ and peptide add-ons are priced separately. No separate consultation fee reported on the standard plan.
How Oak compares on price across our ranking:
| Clinic | Semaglutide Starting Rate | Plan Type | Score |
|---|---|---|---|
| Gala Health | $149/mo | Flat monthly | 8.3/10 |
| Wellorithm | $147/mo | Flat monthly | 8.3/10 |
| Yucca Health | $146/mo entry → ~$206/mo month 2+ | 6-month prepay | 7.8/10 |
| Oak | $133/mo ongoing | No-subscription monthly | 7.7/10 |
| Care Bare Rx | $199/mo | Flat monthly | 7.6/10 |
| Synergy RX | $199/mo | Flat monthly | 7.5/10 |
| Direct Meds | $147/mo | Flat monthly | 7.5/10 |
| Breeze Meds | $199/mo | Flat monthly | 7.3/10 |
Pricing score: 8.0/10. At $133/mo with no subscription lock-in, this Oak review rates it the most affordable no-commitment injectable-and-oral compounded GLP-1 clinic we track. The score is held to 8.0 rather than 9.0 because the promo-vs-ongoing distinction and the tirzepatide price step are not fully detailed in the upfront pricing presentation, and because the state availability gap creates uncertainty about eligibility before checkout. The pricing architecture is otherwise one of the most transparent in the category.
What medications does Oak offer?
This Oak review found a treatment menu that is broader than most sub-$150/mo peers:
Compounded semaglutide — weekly subcutaneous injection, same active ingredient class as Ozempic and Wegovy. Prepared by a licensed 503A compounding pharmacy under a patient-specific prescription. Not FDA-approved. Starting at $133/mo.
Compounded tirzepatide — weekly subcutaneous injection, same active ingredient class as Zepbound and Mounjaro (dual GLP-1/GIP agonist). Not FDA-approved. Starting at $199/mo.
Oral (needle-free) route — Oak offers an oral semaglutide format, making it one of the few clinics in our ranking providing both injection and needle-free access at a sub-$140/mo starting price. Patients with needle aversion or who prefer daily oral dosing have a documented route here. For a broader look at needle-free options, see our oral semaglutide and needle-free GLP-1 guide.
NAD+ and longevity add-ons — Oak includes optional NAD+ injections and peptide add-ons (glutathione referenced on site) not bundled in the base GLP-1 plan. Priced separately. No other clinic in the sub-$150/mo tier pairs compounded GLP-1 with a documented longevity stack — this is the brand differentiation our Oak review found most distinctive.
What Oak does not offer:
- No brand-name Wegovy, Ozempic, Zepbound, or Mounjaro — compounded only
- No microdosing GLP-1 tier (available at Gala Health and Bodybuilding Health+)
- No HRT or hair/sexual-health telehealth lines in the same portal
Treatment score: 8.0/10. Injection plus oral routes plus NAD+ add-ons at this price point earn an 8.0 — one of the widest menus in the sub-$150/mo tier. The score is not 9.0 because Oak lacks brand-name access and the oral formulation details (daily dose, absorption profile) are not publicly detailed before intake.
How does the Oak process work?
Based on our research for this Oak review, the clinical process is:
- Online intake (~5 min) — health history, medications, BMI, and weight-loss goals submitted asynchronously; no live video appointment required
- Same-day licensed provider review — a U.S.-licensed provider reviews intake and determines GLP-1 eligibility; Oak cites a same-day approval timeline for most applicants
- Prescription to licensed compounding pharmacy — if approved, a patient-specific prescription is issued and dispatched to Oak's compounding pharmacy partner
- Free shipping with tracking — medication arrives in temperature-controlled packaging within days; free on every order
- Ongoing health coaching and refill management — health coaching is included in the standard plan; care team access for dosing questions, adjustments, and refills; no required follow-up video calls
No subscription lock-in is the process detail this Oak review found most significant at this price tier. Most telehealth GLP-1 platforms default to 3- or 6-month bundles as the only low-price entry point, meaning a patient who wants to trial GLP-1 before committing faces a higher effective monthly price. Oak's month-to-month model removes that barrier: you can start, assess the program over one cycle, and stop without penalty. For patients uncertain about long-term commitment or comparing options across clinics, this is a material structural advantage.
Experience score: 8.0/10. Same-day approval, free shipping, included health coaching, and no subscription lock-in are above the category baseline at $133/mo. The score is not 9.0 because independent patient-experience data (Trustpilot scale, shipping-time verification) is thinner at Oak than at Yucca Health's benchmark, making it harder to independently verify the claimed timelines.
Clinical score: 7.5/10. Async telehealth with LegitScript certification and licensed provider review before any prescription. The 7.5 score — one point below Gala Health and Yucca Health at 8.0 — reflects: (1) no publicly available provider directory or independently verified credential details; (2) a newer GLP-1 program track record. The oversight model is clinically appropriate and LegitScript-certified; the 7.5 reflects depth of verifiable independent evidence, not a concern about the oversight structure itself.
Oak vs competitors
Here is how our Oak review positions the clinic against the options patients most commonly compare it to:
Oak vs Gala Health (#1, 8.3/10): Gala Health is our Best Overall pick at 8.3/10, with compounded semaglutide from $149/mo on a flat monthly plan — no prepay, HRT and microdosing tiers included, and a stronger independent track record. The $16/mo gap between Gala ($149) and Oak ($133) is the smallest price difference in the ranking, but Gala adds meaningful treatment breadth (HRT, microdosing, broader format menu) that Oak does not. If $149/mo fits your budget and you want a best-in-class independent reputation, Gala is worth the marginal premium. If $133/mo with no-commitment monthly billing is the key factor, Oak's structural advantages are real.
Oak vs Yucca Health (#3, 7.8/10): Yucca Health is Oak's closest direct competitor: both are LegitScript-certified compounded GLP-1 clinics in the $133–$146/mo price range. Yucca Health's edge is a significantly stronger independent trust signal — Trustpilot 4.6/5 across 1,000+ reviews and free UPS 2-Day Air on every order. Our Oak review found these counter-balancing advantages: a lower standard monthly rate ($133 vs $146 entry → ~$206 ongoing from month 2), a needle-free oral route, NAD+ add-ons, and no subscription lock-in. For patients who need needle-free access or want to trial GLP-1 before committing to a prepay, Oak's differentiation is clear. For patients who prioritize the deepest verified patient-outcome track record and free 2-day shipping as non-negotiables, Yucca's 7.8 score edges ahead. See the full ranking for all 13 scores side by side.
Oak vs Wellorithm (#2, 8.3/10): Wellorithm is the only clinic in our ranking offering brand-name Wegovy, Ozempic, Mounjaro, and Zepbound alongside compounded options — plus a needle-free oral route from $147/mo. Wellorithm starts at $147/mo for compounded semaglutide (vs Oak's $133), and does not include NAD+ or longevity add-ons. The $14/mo differential buys brand-name escalation capability at Wellorithm that Oak cannot match. If you anticipate wanting to move to FDA-approved brand-name GLP-1 without switching platforms, Wellorithm is the only place to do it in our ranking. If you want compounded-only at the lowest rate with longevity add-ons, Oak's position is stronger.
Oak vs Direct Meds ($147/mo, 7.5/10): Direct Meds offers a sublingual (needle-free) route from $147/mo — comparable to Oak's oral option at $133/mo. The primary difference this Oak review found is trust profile: Direct Meds carries an active BBB F-rating for billing and cancellation complaints, reflected in a 5.0/10 transparency score. Oak's transparency is 7.0/10. For needle-free access at the absolute lowest price, Oak ($133 oral) undercuts Direct Meds ($147 sublingual) by $14/mo while carrying a meaningfully cleaner trust profile. See the full GLP-1 clinic rankings for the wider context.
Who should choose Oak?
Based on this Oak review, here is the clearest decision framework:
Good fit for Oak:
- You want the lowest standard monthly semaglutide rate in our ranking ($133/mo), without a multi-month prepay requirement
- You need a needle-free (oral) route and want to pay the minimum possible for it
- You want to trial GLP-1 month-to-month with no subscription penalty — Oak's no-lock-in structure is the right fit
- You are interested in longevity/wellness add-ons (NAD+, peptides) alongside GLP-1, accessible from the same platform
- You are comfortable with an async-only clinical model (no required video call) and a newer-but-LegitScript-certified program
Not a good fit for Oak:
- You want brand-name Wegovy, Ozempic, Zepbound, or Mounjaro → Wellorithm (the only clinic in our ranking with brand-name access)
- You want the most independently verified patient-outcome track record → Yucca Health (4.6/5, 1,000+ Trustpilot reviews)
- You need unlimited 24/7 dedicated clinical team support → Synergy RX
- You want a broader wellness menu including HRT or hair/sexual health → Gala Health or Care Bare Rx
- You want a microdosing GLP-1 tier → Gala Health ($149/mo microdosing) or Bodybuilding Health+
Bottom line from this Oak review: Oak is the right choice for patients who want the cheapest no-commitment entry into a LegitScript-certified compounded GLP-1 program — with a needle-free oral route and optional longevity add-ons included. The $133/mo rate is the verified standard monthly price, not a prepay-only headline. The 7.0 transparency score reflects presentation gaps (no state list, promo details) rather than conduct concerns. The 7.5 clinical score reflects a newer track record rather than a deficient oversight model. At the right price for the right patient — particularly those who need needle-free access, want no-subscription flexibility, or are drawn to the longevity-stack add-ons — our Oak review positions it as a genuine and well-earned #4 in the ranking.
Visit Oak → Compounded semaglutide from $133/mo. Oral/needle-free option. No subscription lock-in.
This content is for informational purposes only and does not constitute medical advice. Compounded semaglutide and tirzepatide are not FDA-approved drugs. Eligibility for GLP-1 treatment requires evaluation by a licensed clinician. Individual weight-loss results vary. Consult your physician before starting any GLP-1 medication.
We may earn a commission if you purchase through affiliate links on this page. Affiliate relationships do not influence our scores, which are derived solely from independently verified clinical and pricing evidence. See our affiliate disclosure for full details.
Prices verified June 2026. Last updated July 2026.
Top picks
| Rank | Clinic | Starting Price | Score | Label |
|---|---|---|---|---|
| #1 | Gala Health | $149/mo | 8.3/10 | Best Overall |
| #2 | Wellorithm | $147/mo | 8.3/10 | Best Brand + Compounded |
| #3 | Yucca Health | $146/mo | 7.8/10 | Best Value |
| #4 | Oak | $133/mo | 7.7/10 | Cheapest No Lock-In |
| #5 | Synergy RX | $199/mo | 7.5/10 | Best Support |
Related reading
- How Much Does GLP-1 Weight Loss Cost in 2026?
- Is Compounded Semaglutide Still Legal in 2026?
- Best Needle-Free GLP-1 Programs 2026 (Oral Semaglutide Ranked)
- Semaglutide vs Tirzepatide: Which Is Better for Weight Loss?
- Semaglutide Shortage 2026: What Changed for Buyers
- Semaglutide Ban 2026: Your Access & Timeline
- Full GLP-1 Clinic Rankings & Scores
